Search research articles
Contact Us
Filters
Showing results (621-630 of 739) with videos related to
Page
of 74
Sort By:
Cancer Research
|
September 19, 2007
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells
Yasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, et al.
Neuropathology and Applied Neurobiology
|
April 22, 2018
A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma
K Yu, A S Youshani, F L Wilkinson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
S D Fosså, R T Oliver, S P Stenning, et al.
Diabetes
|
November 18, 2020
Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice
Fernanda M C Sodré, Samal Bissenova, Ylke Bruggeman, et al.
Molecular Immunology
|
December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
Jehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
JCI Insight
|
March 25, 2025
CFTR negatively reprograms Th2 cell responses, and CFTR potentiation restrains allergic airway inflammation
Mark Rusznak, Christopher M Thomas, Jian Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2025
PGI2 restricts trained ILC2 responses in allergic inflammation
Weisong Zhou, Jian Zhang, Allison E Norlander, et al.
Journal of the American Chemical Society
|
September 20, 2019
Monitoring the Formation of Amyloid Oligomers Using Photoluminescence Anisotropy
Bo Jiang, Amir Aliyan, Nathan P Cook, et al.
Clinical and Experimental Immunology
|
December 1, 2019
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H J Close, L F Stead, J Nsengimana, et al.
Frontiers in Immunology
|
August 8, 2025
Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment
Dalia Ibrahim, Melanie Grondin, Kristianne Galpin, et al.
Page
of 74
Search research articles
Search
Showing results (621-630 of 739) with videos related to
Sort By:
Page
of 74
Cancer Research
|
September 19, 2007
The requirement for DNAM-1, NKG2D, and NKp46 in the natural killer cell-mediated killing of myeloma cells
Yasser M El-Sherbiny, Josephine L Meade, Tim D Holmes, et al.
Neuropathology and Applied Neurobiology
|
April 22, 2018
A nonmyeloablative chimeric mouse model accurately defines microglia and macrophage contribution in glioma
K Yu, A S Youshani, F L Wilkinson, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 1, 1997
Prognostic factors for patients with advanced seminoma treated with platinum-based chemotherapy
S D Fosså, R T Oliver, S P Stenning, et al.
Diabetes
|
November 18, 2020
Peptidylarginine Deiminase Inhibition Prevents Diabetes Development in NOD Mice
Fernanda M C Sodré, Samal Bissenova, Ylke Bruggeman, et al.
Molecular Immunology
|
December 25, 2013
Blocking oncogenic RAS enhances tumour cell surface MHC class I expression but does not alter susceptibility to cytotoxic lymphocytes
Jehan J El-Jawhari, Yasser M El-Sherbiny, Gina B Scott, et al.
JCI Insight
|
March 25, 2025
CFTR negatively reprograms Th2 cell responses, and CFTR potentiation restrains allergic airway inflammation
Mark Rusznak, Christopher M Thomas, Jian Zhang, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 7, 2025
PGI2 restricts trained ILC2 responses in allergic inflammation
Weisong Zhou, Jian Zhang, Allison E Norlander, et al.
Journal of the American Chemical Society
|
September 20, 2019
Monitoring the Formation of Amyloid Oligomers Using Photoluminescence Anisotropy
Bo Jiang, Amir Aliyan, Nathan P Cook, et al.
Clinical and Experimental Immunology
|
December 1, 2019
Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H J Close, L F Stead, J Nsengimana, et al.
Frontiers in Immunology
|
August 8, 2025
Transglutaminase 2 regulates ovarian cancer metastasis by modulating the immune microenvironment
Dalia Ibrahim, Melanie Grondin, Kristianne Galpin, et al.
Page
of 74